BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 16, 2024
See today's BioWorld
Home
» Other news to note for April 6, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for April 6, 2022
April 6, 2022
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3CL, Abbvie, Addex, Agenus, Aligos, Alloy, Alvotech, Atara, Atreca, AVM, Awakn, Axantia, Betterlife, Biotech Acquisition, Cellpoint, Dragon Overseas, Golden Mountain, HDT, Intas, Isto, Stada, Neurona, Novartis, Neuro-Bio, Novo Nordisk, Oncotelic, Oragenics, Pregene, Regeneron, SQZ, Synaptogenix, Swanbio, Tegmine, Theracell, Todos, Treadwell, Vigeneron, Zymeworks.
BioWorld
Briefs
Other news to note
Coronavirus